当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析

华熙生物

(688363)

  

流通市值:161.36亿  总市值:161.36亿
流通股本:4.82亿   总股本:4.82亿

华熙生物(688363)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.65亿元,每股收益0.14元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益715962.39万元,未分配利润275046.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产875000.60万元,负债159038.21万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入829,407,051.844,199,089,274.553,163,398,568.642,260,691,517.33
营业总成本752,718,280.033,825,862,023.082,850,484,222.231,981,640,358.55
其他经营收益
营业利润70,898,159.16333,092,312.52291,698,252.81261,036,071.59
利润总额68,019,672.45333,802,004.82291,533,228260,324,427.05
净利润65,004,705.35291,148,370.39252,322,879.32220,803,434.47
每股收益
其他综合收益-20,527,812.338,976,111.4746,603,668.1851,143,889.08
综合收益总额44,476,893.05330,124,481.86298,926,547.5271,947,323.55
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,861,528,714.582,784,992,938.782,599,935,860.652,718,781,372.73
非流动资产:
非流动资产合计5,888,477,275.255,907,514,385.785,869,459,045.595,854,024,415.13
资产总计8,750,005,989.838,692,507,324.568,469,394,906.248,572,805,787.86
流动负债:
流动负债合计1,211,345,560.341,190,006,546.261,040,312,645.931,126,401,367.36
非流动负债:
非流动负债合计379,036,517.05387,353,758.91338,983,708.72381,387,517.96
负债合计1,590,382,077.391,577,360,305.171,379,296,354.651,507,788,885.32
所有者权益(或股东权益):
归属于母公司股东权益合计7,129,780,906.497,085,653,979.197,059,741,796.237,032,912,753.7
股东权益合计7,159,623,912.447,115,147,019.397,090,098,551.597,065,016,902.54
负债和股东权益合计8,750,005,989.838,692,507,324.568,469,394,906.248,572,805,787.86
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计946,110,823.344,700,452,538.273,486,455,542.952,495,776,822.7
经营活动现金流出小计815,150,812.664,073,002,605.953,177,696,511.822,277,444,564.79
经营活动产生的现金流量净额130,960,010.68627,449,932.32308,759,031.13218,332,257.91
投资活动产生的现金流量:
投资活动现金流入小计417,466,228.34463,625,517.03340,184,124.1292,684,934.22
投资活动现金流出小计561,478,184.12728,491,200.09511,958,073.33222,056,165.73
投资活动产生的现金流量净额-144,011,955.78-264,865,683.06-171,773,949.21-129,371,231.51
筹资活动产生的现金流量:
筹资活动现金流入小计66,665,000312,800,683.61219,980,125169,980,125
筹资活动现金流出小计32,019,440.61315,100,080.3308,038,992.47215,892,485.87
筹资活动产生的现金流量净额34,645,559.39-2,299,396.69-88,058,867.47-45,912,360.87
汇率变动对现金及现金等价物的影响-8,475,867.363,998,656.1211,025,045.2112,791,476.54
现金及现金等价物净增加额13,117,746.93364,283,508.6959,951,259.6655,840,142.07
期末现金及现金等价物余额990,893,663.99977,775,917.06673,443,668.03669,332,550.44
补充资料:
现金及现金等价物的净增加额-364,283,508.69-55,840,142.07
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城证券黄淑妍0.790.981.162026-05-08
中金公司徐卓楠,袁华远,黄蔓琪0.911.06--2026-05-06
申万宏源王盼,聂霜,王立平0.901.051.252026-04-30
中国银河程培,李璐昕0.730.850.992026-04-30
财通证券耿荣晨0.881.051.222026-04-26
TOP↑